These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 4805964)
1. Retardation of growth of melanoma transplants in hamsters injected with fetal cells. el-Domeiri AA; Sabet TY; Das Gupta TK Surg Forum; 1973; 24():123-4. PubMed ID: 4805964 [No Abstract] [Full Text] [Related]
2. The effect of pretreatment with allogeneic fetal cells on hamster melanoma. El-Domeiri AA; Sabet TY; Das Gupta TK J Med; 1976; 7(2):103-12. PubMed ID: 1064681 [TBL] [Abstract][Full Text] [Related]
3. The susceptibility of fetal rat skin in different immunologic environments to neoplastic induction with Shope papilloma virus. Kreider JW; Breedis C Cancer Res; 1969 May; 29(5):989-93. PubMed ID: 4889110 [No Abstract] [Full Text] [Related]
4. Inhibition of experimental tumor growth in hamsters by small direct currents. Schauble MK; Habal MB; Gullick HD Arch Pathol Lab Med; 1977 Jun; 101(6):294-7. PubMed ID: 301019 [TBL] [Abstract][Full Text] [Related]
5. Clinical experiences in immunotherapy of cancer. Krementz ET; Samuels MS; Wallace JH; Benes EN Surg Gynecol Obstet; 1971 Aug; 133(2):209-17. PubMed ID: 5284416 [No Abstract] [Full Text] [Related]
6. Characterization of surface antigens of transplantable melanomas in hamster on the basis of the macrophage migration inhibition test. Kozłowska K; Zurawska-Czupa B; Kostulak A Arch Immunol Ther Exp (Warsz); 1981; 29(1):137-42. PubMed ID: 7283676 [TBL] [Abstract][Full Text] [Related]
7. [Evidence for tumor immunity in human malignant melanoma]. Nagel GA Schweiz Med Wochenschr; 1970 Jun; 100(23):995-1000. PubMed ID: 4947017 [No Abstract] [Full Text] [Related]
8. [Therapeutic experiments on the hamster melanoma (author's transl)]. Schuppli R Dermatologica; 1981; 163(1):71-7. PubMed ID: 7274518 [No Abstract] [Full Text] [Related]
9. Estimation of macrophage IL-10 and NO secretion in the cytotoxicity against transplantable melanomas in relation to the progression of these tumours. Kozłowska K; Cichorek M; Zarzeczna M Folia Morphol (Warsz); 2002; 61(3):127-31. PubMed ID: 12416926 [TBL] [Abstract][Full Text] [Related]
10. Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10. Watanabe D; Goshima F; Mori I; Tamada Y; Matsumoto Y; Nishiyama Y J Dermatol Sci; 2008 Jun; 50(3):185-96. PubMed ID: 18226503 [TBL] [Abstract][Full Text] [Related]
11. Xenogeneic DNA immunization in melanoma models for minimal residual disease. Hawkins WG; Gold JS; Blachere NE; Bowne WB; Hoos A; Lewis JJ; Houghton AN J Surg Res; 2002 Feb; 102(2):137-43. PubMed ID: 11796010 [TBL] [Abstract][Full Text] [Related]
12. [Dendritic cells--a new weapon in therapy of melanoma?]. Enk A Hautarzt; 1996 Jun; 47(6):488-90. PubMed ID: 8778075 [No Abstract] [Full Text] [Related]
13. Targeting the stromal fibroblasts: a novel approach to melanoma therapy. Smalley KS; Lioni M; Herlyn M Expert Rev Anticancer Ther; 2005 Dec; 5(6):1069-78. PubMed ID: 16336098 [TBL] [Abstract][Full Text] [Related]